Circulating Tumor DNA Detection for Recurrence Monitoring of Stage I Non‐Small Cell Lung Cancer Treated With Microwave Ablation
ABSTRACT Purpose As microwave ablation continues to be used in patients with inoperable stage I non‐small cell lung cancer (NSCLC), it is particularly important to monitor efficacy. Whether plasma ctDNA detection can predict its efficacy should be illustrated. Methods We recruited 43 patients with i...
Saved in:
Main Authors: | Lin Cheng, Sheng Xu, Yu‐feng Wang, Sheng‐wei Li, Bin Li, Xiao‐Guang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.15534 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative analysis of EGFR mutations in circulating tumor DNA and primary tumor tissues from lung cancer patients using BEAMing PCR
by: Duhita Mirikar, et al.
Published: (2025-01-01) -
Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study
by: Shuta Ohara, MD, PhD, et al.
Published: (2025-03-01) -
Complications of microwave ablation in patients with persistent/recurrent hyperparathyroidism after surgical or ablative treatment
by: Ying Wei, et al.
Published: (2024-12-01) -
Computed tomography-guided microwave ablation therapy for pediatric adrenal neuroblastoma with lung nodule a case report
by: Shu-Cong Peng, et al.
Published: (2025-01-01) -
Electromagnetic navigation system for computed tomography-guided synchronous percutaneous lung biopsy and microwave ablation of pulmonary nodules: a prospective, single-center, single-arm clinical study
by: Shengwei Li, et al.
Published: (2024-12-01)